5 Top-Ranked Stocks Likely to Deliver Earnings Beats

Zacks screened more than 7,700 stocks to identify 11 potential earnings-beat candidates, highlighting Aveanna Healthcare, Fortinet, Tenet Healthcare, Arrow Electronics and Valero Energy. The five stocks carry Zacks Rank #1 or #2 ratings, positive Earnings ESPs and average EPS surprises over the past four quarters of 49.26% for AVAH, 20.34% for FTNT, 22.70% for THC, 34.40% for ARW and 26.80% for VLO. The article presents these names as prospective pre-earnings opportunities rather than reporting new company results or guidance.

Analysis

This is a low-information screen rather than a differentiated catalyst: historical estimate beats are widely observable and often reflect conservative sell-side modeling, not incremental operating momentum. The principal earnings risk is asymmetry—stocks priced for a beat can decline on an in-line result or guidance that fails to lift forward estimates. Do not treat the listed names as a basket; their earnings drivers are largely uncorrelated and require separate underwriting.

FTNT offers the cleanest relative setup only if billings, deferred revenue and firewall refresh demand reaccelerate simultaneously; a headline EPS beat driven by expense control would not justify multiple expansion. A positive read-through would favor PANW and CHKP modestly, but FTNT-specific share gains could instead pressure them. Over the next 1-3 months, the decisive variable is whether management raises durable growth expectations rather than merely delivers a quarterly margin beat.

For THC and AVAH, reimbursement and labor-cost trends matter more than consensus EPS. THC's higher-quality catalyst would be sustained USPI same-facility growth and continued deleveraging, while AVAH needs evidence that state-rate and authorization dynamics convert into cash flow; both can report accounting beats without improving equity value. In refining, VLO is a macro trade disguised as an earnings trade: crack spreads, renewable diesel economics and refinery utilization will dominate any surprise, with MPC and PSX the more relevant comparables.

Contrarian view: the screen's publication may create modest retail attention but is unlikely to alter institutional positioning. ARW is the least suitable pre-earnings long absent distributor inventory and book-to-bill data; electronics distribution earnings can beat through working-capital timing while signaling weak end demand. The better use is as a monitoring list for estimate revisions and guidance dispersion, not a directional event basket.

Key Decisions for Investors

• No broad long basket: wait for pre-release estimate revisions and implied moves. Initiate event risk only where implied volatility is below the historical post-earnings move; the article provides neither metric.
• Watch FTNT for a long versus CHKP over the 1-3 month post-print window only if billings/deferred revenue accelerate and forward revenue estimates rise. Exit on a beat driven primarily by opex leverage or on billings deceleration; target 8-12% relative upside versus 5% downside.
• Prefer THC over AVAH for healthcare-services exposure through the next earnings cycle if leverage continues to decline and ambulatory-care growth supports cash generation. Avoid AVAH until operating cash flow and payer-rate realization independently confirm that reported EPS converts to deleveraging.
• Trade VLO tactically only with refining fundamentals: long VLO or XLE on widening Gulf Coast crack spreads and stable utilization; reduce if cracks compress materially or renewable-diesel margins deteriorate. Use MPC as a relative-value hedge if the thesis is sector-wide rather than VLO-specific.
• Set an ARW alert for book-to-bill, inventory days and free-cash-flow conversion. A positive EPS surprise without improving order trends is a fade/watch-item rather than a long signal; weaker demand would also be a cautionary read-through for AVT and electronics-component suppliers.